President & CEO Kakkis Emil D was granted 71,177 shares and sold $1,240,411 worth of shares (54,404 units at $22.80), increasing direct ownership by 3% to 658,994 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

RARE· Ultragenyx Pharmaceutical Inc.

Health Care

Original source

President & CEO Kakkis Emil D was granted 71,177 shares and sold $1,240,411 worth of shares (54,404 units at $22.80), increasing direct ownership by 3% to 658,994 units (SEC Form 4) | Quantisnow